P

Inventor

ZHOU JIACHENG

US89 patents
⚠️ This page may combine multiple inventors who share the name “ZHOU JIACHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

33 patents
US9290506B2Mar 22, 2016

Processes for preparing JAK inhibitors and related intermediate compounds

INCYTE CORP60 citations98
US11174257B2Nov 16, 2021

Salts of an FGFR inhibitor

INCYTE CORP21 citations94
US10626114B2Apr 21, 2020

Crystalline solid forms of a BET inhibitor

INCYTE CORP15 citations94
US10329305B2Jun 25, 2019

Amorphous solid form of a BET protein inhibitor

INCYTE CORP16 citations94
US10189832B2Jan 29, 2019

Crystalline solid forms of a BET inhibitor

INCYTE CORP23 citations94
US10336759B2Jul 2, 2019

Salts and processes of preparing a PI3K inhibitor

INCYTE CORP18 citations93
US10329255B2Jun 25, 2019

Salts of an LSD1 inhibitor

INCYTE CORP15 citations93
US9862705B2Jan 9, 2018

Salts of a pim kinase inhibitor

INCYTE CORP13 citations92
US9802957B2Oct 31, 2017

Processes of preparing a JAK1 inhibitor and new forms thereto

INCYTE CORP28 citations92
US9321755B2Apr 26, 2016

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

INCYTE CORP15 citations92
US12030882B2Jul 9, 2024

Crystalline solid forms of a bet inhibitor

INCYTE CORP3 citations86
US11760756B2Sep 19, 2023

Crystalline form of a PD-1/PD-L1 inhibitor

INCYTE CORP9 citations86
US11753406B2Sep 12, 2023

Salts of a PD-1/PD-L1 inhibitor

INCYTE CORP9 citations86
US11377446B2Jul 5, 2022

Crystalline solid forms of a BET inhibitor

INCYTE CORP8 citations86
US11866451B2Jan 9, 2024

Salts and crystalline forms of a PD-1/PD-L1 inhibitor

INCYTE CORP7 citations85
US11780836B2Oct 10, 2023

Process of preparing a PD-1/PD-L1 inhibitor

INCYTE CORP8 citations85
US11472801B2Oct 18, 2022

Crystalline forms of a FGFR inhibitor and processes for preparing the same

INCYTE CORP9 citations84
US11104682B2Aug 31, 2021

Salts of TAM inhibitors

INCYTE CORP7 citations84
US11091480B2Aug 17, 2021

Crystalline solid forms of a BET inhibitor

INCYTE CORP8 citations84
US10858372B2Dec 8, 2020

Amorphous solid form of a BET protein inhibitor

INCYTE CORP10 citations84
US10799509B2Oct 13, 2020

Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same

INCYTE CORP3 citations84
US10633387B2Apr 28, 2020

Salts of TAM inhibitors

INCYTE CORP10 citations84
US10450325B2Oct 22, 2019

Processes of preparing a JAK1 inhibitor and new forms thereto

INCYTE CORP11 citations84
US10245265B2Apr 2, 2019

Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same

INCYTE CORP6 citations84
US9718834B2Aug 1, 2017

Processes and intermediates for making a JAK inhibitor

INCYTE CORP10 citations84
US11866434B2Jan 9, 2024

Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

INCYTE CORP7 citations83
US11084822B2Aug 10, 2021

Salts and processes of preparing a PI3K inhibitor

INCYTE CORP7 citations83
US10968200B2Apr 6, 2021

Salts of an LSD1 inhibitor and processes for preparing the same

INCYTE CORP5 citations83
US10899736B2Jan 26, 2021

Processes and intermediates for making a JAK inhibitor

INCYTE CORP7 citations83
US10723700B2Jul 28, 2020

Salts of an LSD1 inhibitor

INCYTE CORP7 citations83
US12187730B2Jan 7, 2025

Salts of TAM inhibitors

INCYTE CORP1 citations75
US12024517B2Jul 2, 2024

Salts of an FGFR inhibitor

INCYTE CORP3 citations75
US12084443B2Sep 10, 2024

Process of preparing a PD-1/PD-L1 inhibitor

INCYTE CORP5 citations74

ZHOU JIACHENG

5 patents

RIB X PHARMACEUTICALS INC

3 patents

INCYTE HOLDINGS CORP

3 patents

WENG LINGKAI

2 patents

BRISTOL MYERS SQUIBB CO

2 patents

BRISTOL MYERS SQUIBB PHARMA CO

1 patent

COMBS ANDREW P

1 patent

Showing the top 50 of 89 patents by PatentIndex Score.